Cargando…
Bladder pathology /
The human urinary bladder is subject to a unique and extraordinarily diverse array of congenital, inflammatory, metaplastic, and neoplastic abnormalities. This book provides contemporary, comprehensive, and evidence-based practice information for pathologists, urologists, oncologists, and other medi...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hoboken :
John Wiley & Sons,
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover; Title Page; Copyright; Preface; Chapter 1: Normal Anatomy and Histology; 1.1 Embryology; 1.2 Anatomy; 1.3 Normal Histology; 1.4 The Urachus; 1.5 The Renal Pelvis and Ureters; 1.6 The Urethra; 1.7 Immunohistochemical Findings; References; Chapter 2: Inflammatory and Infectious Conditions; 2.1 Acute and Chronic Cystitis and Their Variants; 2.2 Granulomatous Cystitis; 2.3 Other Infectious Cystitides; References; Chapter 3: Urothelial Metaplasia and Hyperplasia; 3.1 von Brunn Nests; 3.2 Cystitis Cystica; 3.3 Cystitis Glandularis and Intestinal Metaplasia; 3.4 Squamous Metaplasia.
- 3.5 Nephrogenic Metaplasia (Nephrogenic Adenoma)3.6 Urothelial Hyperplasia; References; Chapter 4: Polyps and Other Nonneoplastic Benign Conditions; 4.1 Polyps and Polypoid Lesions of the Bladder; 4.2 Miscellaneous Nonneoplastic Benign Conditions; 4.3 Metabolic Deposits; 4.4 Other Rare Benign Lesions; References; Chapter 5: Benign Epithelial Tumors; 5.1 Papilloma of the Urinary Bladder; 5.2 Inverted Papilloma; 5.3 Squamous Papilloma; 5.4 Villous Adenoma and Tubulovillous Adenoma; 5.5 Urachal Adenoma; References; Chapter 6: Flat Urothelial Lesions with Atypia and Urothelial Dysplasia.
- 6.1 Reactive Urothelial Atypia6.2 Atypia of Unknown Significance; 6.3 Urothelial Dysplasia; 6.4 Molecular Alterations in Flat Lesions; References; Chapter 7: Urothelial Carcinoma in Situ; 7.1 Definition, Terminology, and Historical Perspective; 7.2 Clinical Features; 7.3 Special Considerations; 7.4 Histopathology and Diagnostic Criteria; 7.5 Variants of Urothelial Carcinoma in Situ; 7.6 Differential Diagnosis; 7.7 Diagnostic and Predictive Biomarkers; 7.8 Prognosis; 7.9 Molecular Characteristics; References; Chapter 8: Bladder Cancer: General Features; 8.1 Epidemiology and Risk Factors.
- 8.2 Genetic Predisposition and Syndromic Associations8.3 Clinical Features and Natural History of Bladder Cancer; 8.4 Morphologic Characteristics of Invasive Urothelial Carcinoma; 8.5 Urothelial Carcinoma in Young Adults; 8.6 Prognosis of Invasive Urothelial Cancer; 8.7 Field Cancerization and Tumor Multicentricity; 8.8 The Origin of Bladder Cancer; 8.9 Molecular Genetics; 8.10 Molecular Therapies Targeting Molecular Pathways; references; Chapter 9: Grading of Bladder Cancer; 9.1 Pathologic Classification and Grading of Urothelial Carcinoma: An Overview.
- 9.2 Histologic Grading According to the 1973 WHO Classification9.3 Histologic Grading According to the 1998 ISUP/2004 WHO Classification; 9.4 Histologic Grading According to the 1999 WHO Classification; 9.5 Should We Abandon PUNLMP?; 9.6 Histologic Grading of Urothelial Carcinoma: Current Proposal; 9.7 Grading of Invasive Bladder Carcinoma; 9.8 Tumor Heterogeneity; 9.9 Molecular Grading; 9.10 Future Prospectives; References; Chapter 10: Stage pT1 Urothelial Carcinoma; 10.1 Diagnosis of Lamina Propria Invasion (pT1 Urothelial Carcinoma).